February 26, 2020 / 10:35 PM / a month ago

BRIEF-Arena Posts Quarterly Loss Per Share Of $1.76

Feb 26 (Reuters) - Arena Pharmaceuticals Inc:

* ARENA ANNOUNCES MANAGEMENT AND PROGRAM UPDATES AND REPORTS FOURTH QUARTER AND FULL-YEAR 2019 FINANCIAL RESULTS

* APPOINTS KEVIN LIND AS PRESIDENT AND CHIEF EXECUTIVE OFFICER OF ARENA NEUROSCIENCE, INC

* APPOINTS LAURIE STELZER AS EXECUTIVE VICE PRESIDENT AND CHIEF FINANCIAL OFFICER OF ARENA

* EXPECTS TO DELIVER UP TO EIGHT MAJOR DATA READOUTS BETWEEN 2020-21 AND MULTIPLE INDS

* QTRLY LOSS PER SHARE $1.76

* Q4 EARNINGS PER SHARE VIEW $-1.55 — REFINITIV IBES DATA Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below